Can AI fix health care? In the chaos of emergency rooms, the technology comes up short
AI scribes help ER doctors document care faster, but the extra minutes per patient aren't translating into shorter wait times or faster test results.
News Search
Search results for Statnews
Search Results
24 results found
Coroner releases details of infants who died amid growing Pennsylvania measles outbreak
CDC officials have not said whether they will count either death as measles-associated; agency's website still carries disclaimer about them.
FDA names acting heads of drug and vaccine centers to permanent roles
Michael Davis will lead the FDA's Center for Drug Evaluation and Research, and Karim Mikhail will run the Center for Biologics Evaluation and Research.
FDA warns an API supplier about residue on walls, a corroded product line, and open-toed sandals
In response to filth and possible contamination, the FDA last month halted all product shipments from the company into the U.S.
A breakthrough pancreatic cancer drug won approval. They still struggle to access it
After Rasonque, a pancreatic cancer drug from Revolution Medicines, won FDA approval, patients learned it can take insurance coverage weeks to catch up.
Hospitals pursue deals to ensure survival as Trump’s Medicaid cuts loom
Rural health systems seeking partnerships to survive fuel a debate over market competition versus higher costs of care in part 3 of the series 'Unraveled.'
Reynolds is selling fruity new vapes unauthorized by FDA
Some states sell vaping products by Reynolds American even though they aren’t authorized by the Food and Drug Administration.
It’s time to take the gloves off during vaccination
If all 18 million health care workers in the U.S. get a flu shot, that equals 36 million gloves, or 108 metric tons of garbage.
Roivant lung disease drug hits mid-stage study goals
Roivant reports its experimental drug mosliciguat for a type of pulmonary hypertension achieved goals of mid-stage study.
Inhibrx claims first win for long-sought immunotherapy target
Inhibrx’s antibody INBRX-106 showed success in HPV-positive head and neck cancers.
AstraZeneca’s experimental COPD treatment posts strong results in late-stage studies
The data suggest the drug, known as 'tozo,' could be competitive with other new COPD treatments, and potentially reach more patients.
Novo Nordisk stops two cardiovascular trials of drug aimed at lowering inflammation
The studies of a drug called ziltivekimab were aimed at taming inflammation as a way to improve cardiovascular health.
Not so fast: Diabetes association panel not done reviewing ejections from its June meeting
In June, five members of the American Diabetes Association were ejected from a conference. A panel is still reviewing what happened.
Why are drug overdose deaths declining?
Factors include increased access to naloxone, expanded access to medications for opioid use disorder, and greater tolerance for harm reduction efforts.
Make infectious disease data boring again
The CDC’s fight with Pennsylvania over measles deaths is undermining trust and raising concerns about politicization.
Novartis’ experimental cardiovascular drug fails a pivotal study
Other pharmaceutical companies, including Amgen and Eli Lilly, are also developing therapies to lower levels of Lp(a).
After failure of Angelman syndrome drug, experts see hope in other experimental therapies
Like Ultragenyx, Ionis and Oak Hill Bio are developing their own antisense treatments for Angelman syndrome.
Lindsay Clancy case exposes dangers of fragmented U.S. health system, experts say
Before the deaths of her children, Clancy got 30 prescriptions from five clinicians and two hospitals. Lack of coordination cited as key factor in tragic outcome.
The FDA removed the red tape around one of the best drugs for children with schizophrenia. But the fear rem...
For children with schizophrenia, clozapine can be close to miraculous. Doctors are too reluctant to use it, writes expert.
Top Boston hospitals clash over Medicare Advantage network after split
Mass General Brigham's Medicare Advantage plan is dropping coverage of Dana-Farber, a top cancer center.
Recipients of gene-edited pig kidneys successfully receive human organs
The pair of cases mark a milestone for the biotech company eGenesis in its wider effort to advance xenografts.
‘Tactical athletes’ get new guidance for cardiovascular fitness
Tactical athletes — astronauts, firefighters, police — face unique cardiovascular risks. Most dangerous time is right before going into action.
FDA pilot offers generative AI medical devices a path to patients before they are authorized
TEMPO, FDA's pilot program, offers the regulators a hands-on experience with medical devices that rely on generative AI technology in real world settings.
Abivax has still not been acquired. What’s going on?
In this week's edition of "Adam's Biotech Scorecard," Adam suggests there could be explanations for the absence of news on Abivax.